statistiche ricercatore

Continente	#
NA - Nord America	861
EU - Europa	820
AS - Asia	455
SA - Sud America	61
Continente sconosciuto - Info sul continente non disponibili	35
AF - Africa	13
Totale	2.245

Nazione	#
US - Stati Uniti d'America	834
IT - Italia	360
SG - Singapore	148
CN - Cina	124
RU - Federazione Russa	118
GB - Regno Unito	74
DE - Germania	57
VN - Vietnam	56
FI - Finlandia	41
BR - Brasile	38
FR - Francia	36
UA - Ucraina	32
SE - Svezia	29
IN - India	26
BD - Bangladesh	20
TR - Turchia	19
IE - Irlanda	17
CA - Canada	13
AR - Argentina	11
HK - Hong Kong	10
MX - Messico	10
PL - Polonia	9
JP - Giappone	8
NL - Olanda	8
PK - Pakistan	8
KR - Corea	7
PH - Filippine	7
ES - Italia	6
LT - Lituania	6
AT - Austria	4
CH - Svizzera	4
EC - Ecuador	4
BE - Belgio	3
HU - Ungheria	3
MA - Marocco	3
PE - Perù	3
SA - Arabia Saudita	3
TW - Taiwan	3
ZA - Sudafrica	3
CO - Colombia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
ID - Indonesia	2
IL - Israele	2
IR - Iran	2
PT - Portogallo	2
RS - Serbia	2
ZW - Zimbabwe	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
CL - Cile	1
DZ - Algeria	1
EG - Egitto	1
EU - Europa	1
GH - Ghana	1
GT - Guatemala	1
HR - Croazia	1
JM - Giamaica	1
JO - Giordania	1
KW - Kuwait	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MK - Macedonia	1
MQ - Martinica	1
NP - Nepal	1
PR - Porto Rico	1
PY - Paraguay	1
RO - Romania	1
SI - Slovenia	1
SY - Repubblica araba siriana	1
TG - Togo	1
TH - Thailandia	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.211

Nome	#
Sviluppo ed umanizzazione di un anticorpo in formato scFv contro β-1,3 glucano	311
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response	262
Humanization of Antibodies using a Statistical Inference Approach	242
A biotechnological approach for the production of new protein bioplastics	228
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?	199
A new humanized antibody is effective against pathogenic fungi in vitro	194
A biotechnological approach for the production of new protein bioplastics	172
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection	154
Development and in vitro characterization of a humanized scFv against fungal infections	147
AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability	109
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study	109
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody	105
Predicting the success of an antibody: Biochemical and biophysical characterization of the humanized monoclonal antibody Dia-T51	13
Totale	2.245

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	118	0	8	11	18	5	11	2	17	7	5	15	19
2022/2023	143	11	5	9	11	8	23	0	20	27	11	9	9
2023/2024	89	9	1	2	20	9	13	4	7	0	9	2	13
2024/2025	513	15	9	93	40	22	26	87	41	40	38	64	38
2025/2026	801	84	57	83	121	76	63	86	27	41	77	56	30
2026/2027	58	45	13	0	0	0	0	0	0	0	0	0	0
Totale													2.245